Is OCEL or QYLD a better dividend investment in 2026?

OCEL currently yields 72.93% with a 5% 5-year dividend growth rate. QYLD yields 12.24% with -2.1% growth. The better choice depends on your goal: OCEL offers higher current income.

What is the dividend yield difference between OCEL and QYLD?

OCEL has a forward dividend yield of 72.93% ($2.00/share annually). QYLD yields 12.24% ($2.04/share annually). The yield gap is 60.69 percentage points.

Home › Compare › OCEL vs QYLD

OCEL vs QYLD: Dividend Comparison 2026

OCEL yields 72.93% · QYLD yields 12.24%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 OCEL wins by $1.18M in total portfolio value

INVESTMENT

TIME HORIZON10 years

OCEL

● Live price

72.93%

Share price

$2.74

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.20M

Annual income

$325,655.22

Full OCEL calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

12.24%

Share price

$16.70

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.5K

Annual income

$6,038.84

Full QYLD calculator →

Portfolio growth — OCEL vs QYLD

📍 OCEL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	OCEL	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, OCEL + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

OCEL pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCEL

Annual income on $10K today (after 15% tax)

$6,198.72/yr

After 10yr DRIP, annual income (after tax)

$276,806.94/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,040.82/yr

After 10yr DRIP, annual income (after tax)

$5,133.01/yr

At 15% tax rate, OCEL beats the other by $271,673.92/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCEL + QYLD for your $10,000?

OCEL: 50%QYLD: 50%

100% QYLD50/50100% OCEL

Portfolio after 10yr

$615.3K

Annual income

$165,847.03/yr

Blended yield

26.95%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCEL buys

QYLD buys

No recent congressional trades found for OCEL or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricOCELQYLD

Forward yield	72.93% ✓	12.24%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1.20M	$26.5K ✓
Annual income after 10y	$325,655.22 ✓	$6,038.84
Total dividends collected	$1.03M	$28.5K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: OCEL vs QYLD ($10,000, DRIP)

Year	OCEL Portfolio	OCEL Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$17,993	$7,292.62	$10,384	$1,224.49	+$7.6K → OCEL
2	$31,515	$12,262.92	$10,900	$1,388.18	+$20.6K → OCEL
3	$53,795	$20,073.98	$11,576	$1,590.76	+$42.2K → OCEL
4	$89,585	$32,023.91	$12,447	$1,844.20	+$77.1K → OCEL
5	$145,696	$49,840.41	$13,567	$2,164.97	+$132.1K → OCEL
6	$231,650	$75,755.11	$15,003	$2,576.05	+$216.6K → OCEL
7	$360,433	$112,567.38	$16,853	$3,110.04	+$343.6K → OCEL
8	$549,352	$163,689.57	$19,251	$3,813.85	+$530.1K → OCEL
9	$820,973	$233,165.47	$22,390	$4,756.08	+$798.6K → OCEL
10	$1,204,096	$325,655.22	$26,548	$6,038.84	+$1.18M → OCEL

OCEL vs QYLD: Complete Analysis 2026

OCEL — Stock

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent, which is in Phase I/II clinical trial to treat COVID-19. The company also provides independent education, advertising, and marketing services to medical and other healthcare, anti-aging, and regenerative service providers. It has a research and development agreement with the Centers for Disease Control and Prevention to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection; and an agreement with Oklahoma State University to evaluate Zofin for the treatment of respiratory diseases caused by virus infections of pandemic potential. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida.

Full OCEL Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this OCEL vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCEL vs SCHD OCEL vs JEPI OCEL vs O OCEL vs KO OCEL vs MAIN OCEL vs XYLD OCEL vs JEPQ OCEL vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.